ALLR
Price
$0.94
Change
+$0.06 (+6.82%)
Updated
Aug 22 closing price
Capitalization
13.81M
NCNA
Price
$3.44
Change
+$0.13 (+3.93%)
Updated
Aug 22 closing price
Capitalization
6.56M
Interact to see
Advertisement

ALLR vs NCNA

Header iconALLR vs NCNA Comparison
Open Charts ALLR vs NCNABanner chart's image
Allarity Therapeutics
Price$0.94
Change+$0.06 (+6.82%)
Volume$318.54K
Capitalization13.81M
NuCana
Price$3.44
Change+$0.13 (+3.93%)
Volume$420K
Capitalization6.56M
ALLR vs NCNA Comparison Chart in %
Loading...
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLR vs. NCNA commentary
Aug 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Hold and NCNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2025
Stock price -- (ALLR: $0.94 vs. NCNA: $3.44)
Brand notoriety: ALLR and NCNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 72% vs. NCNA: 51%
Market capitalization -- ALLR: $13.81M vs. NCNA: $6.56M
ALLR [@Biotechnology] is valued at $13.81M. NCNA’s [@Biotechnology] market capitalization is $6.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 2 FA rating(s) are green whileNCNA’s FA Score has 1 green FA rating(s).

  • ALLR’s FA Score: 2 green, 3 red.
  • NCNA’s FA Score: 1 green, 4 red.
According to our system of comparison, ALLR is a better buy in the long-term than NCNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 4 TA indicator(s) are bullish while NCNA’s TA Score has 5 bullish TA indicator(s).

  • ALLR’s TA Score: 4 bullish, 5 bearish.
  • NCNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NCNA is a better buy in the short-term than ALLR.

Price Growth

ALLR (@Biotechnology) experienced а -1.40% price change this week, while NCNA (@Biotechnology) price change was -7.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLR($13.8M) has a higher market cap than NCNA($6.56M). ALLR YTD gains are higher at: -19.265 vs. NCNA (-98.555). NCNA has higher annual earnings (EBITDA): -16.98M vs. ALLR (-23.16M). ALLR (0) and NCNA (0) have equivalent revenues.
ALLRNCNAALLR / NCNA
Capitalization13.8M6.56M210%
EBITDA-23.16M-16.98M136%
Gain YTD-19.265-98.55520%
P/E Ratio0.16N/A-
Revenue00-
Total Cash25.2MN/A-
Total Debt1.36MN/A-
FUNDAMENTALS RATINGS
NCNA: Fundamental Ratings
NCNA
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRNCNA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LU3.070.17
+5.86%
Lufax Holding Ltd
HBNB2.230.09
+4.29%
Hotel101 Global Holdings Corp.
HOLX68.261.09
+1.62%
Hologic
IMUX0.950.01
+0.54%
Immunic
SBFM1.40-0.02
-1.41%
Sunshine Biopharma Inc

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with TAOX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
+7.46%
TAOX - ALLR
87%
Closely correlated
+18.60%
AGEN - ALLR
87%
Closely correlated
-1.09%
RNAC - ALLR
86%
Closely correlated
+2.46%
NCNA - ALLR
86%
Closely correlated
+3.93%
NRXP - ALLR
81%
Closely correlated
+4.35%
More

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with RNAC. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
+3.93%
RNAC - NCNA
93%
Closely correlated
+2.46%
AGEN - NCNA
93%
Closely correlated
-1.09%
TAOX - NCNA
92%
Closely correlated
+18.60%
ALLR - NCNA
86%
Closely correlated
+7.46%
NRXP - NCNA
85%
Closely correlated
+4.35%
More